Taken together, our results demonstrate that ubiquitin is overexpressed in NSCLC and that downregulation of ubiquitin inhibits the proliferation and enhances the efficacy of radiotherapy via multiple pathways in NSCLC cells both in vitro and in vivo. This evidence concerns the gene UBA52 and non-small cell lung carcinoma.